New Therapeutic Approaches to Mendelian Disorders
Open Access
- 26 August 2010
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 363 (9), 852-863
- https://doi.org/10.1056/nejmra0907180
Abstract
Progress in the treatment of genetic disorders has derived from insight into their causes and has focused on nutritional limitation of a substrate, the purging of a toxic metabolite, or compensatory expression of a protein whose deficiency causes disease, through gene delivery. In this review, I focus on therapeutic strategies that exploit a precise understanding of the pathogenesis of a mendelian disease, giving examples that illustrate the strengths and limitations of each approach, as well as the potential for broadening its application to the treatment of more common disorders.Keywords
This publication has 70 references indexed in Scilit:
- HumanRPE65Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 YearHuman Gene Therapy, 2009
- TAT-based drug delivery system – new directions in protein delivery for new hopes?Expert Opinion on Drug Delivery, 2009
- Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCIDImmunologic Research, 2009
- Gene Therapy for Immunodeficiency Due to Adenosine Deaminase DeficiencyNew England Journal of Medicine, 2009
- Lysosomal Storage Diseases and the Blood-Brain BarrierCurrent Pharmaceutical Design, 2008
- Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006)Clinical Immunology, 2007
- Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis IProceedings of the National Academy of Sciences, 2004
- Trafficking of lysosomal enzymes in normal and disease states.Journal of Clinical Investigation, 1986
- A hypothesis for I-cell disease: Defective hydrolases that do not enter lysosomesBiochemical and Biophysical Research Communications, 1972
- Hurler and Hunter Syndromes: Mutual Correction of the Defect in Cultured FibroblastsScience, 1968